Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy-Reference-Cited by-同舟云学术

Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy

Published:2016-10 Issue:2 Volume:380 Page:413-423
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Mirzaei Hamid Reza,Mirzaei Hamed,Lee Sang Yun,Hadjati Jamshid,Till Brian G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference164 articles.

1. Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus;Yee;J. Immunol,1996

2. Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions;Hughes;Hum. Gene Ther,2005

3. Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies;Beatty;Cancer Immunol. Res,2014

4. Chimeric antigen receptor–and TCR-modified T cells enter main street and wall street;Barrett;J. Immunol,2015

5. Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma;Louis;Blood,2011

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor Therapy in Acute Myeloid Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Function of gamma delta (γδ) T cell in cancer with special emphasis on cervical cancer;Human Immunology;2023-12

3. γδ T cells: origin and fate, subsets, diseases and immunotherapy;Signal Transduction and Targeted Therapy;2023-11-22

4. Challenges and new technologies in adoptive cell therapy;Journal of Hematology & Oncology;2023-08-18

5. Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers;Molecular Therapy - Oncolytics;2023-06